Key Drivers
- Margin rebound
- Strong liquidity
- High leverage
AIAI Summary
HNGE is transitioning from a pure growth story into a scaled digital-health operator with real operating leverage—47% revenue growth, 85% gross margins, and 23% free-cash-flow margins—but after the sharp run-up and 6.6x sales valuation, the investment now depends on proving migraine, public-sector, and engagement gains can sustain this expansion without margin compression.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin rebound
- •Strong liquidity
- •High leverage
HNGE's Q1 2026 showed strong profitability, cash generation, and liquidity, but leverage remains elevated and the stock still looks expensive versus sales and book value.
Price Behavior
Key Price Behavior Insights:
- •Higher-highs trend
- •Breakout holding
- •Momentum cooling
HNGE has trended strongly higher over the last month, holding its breakout above $49.75, but it is now extended with near-term resistance at $55.00–$56.02 and support around $54.00–$54.50.
Sharp breakout above $49.75 and surge to $54.84 indicate extended short-term momentum
Sentiment & News
Key News Insights:
- •Record Q1 growth
- •Broader care expansion
- •AI leverage gains
Hinge Health posted record Q1 results, raised guidance, and expanded beyond musculoskeletal care, with strong engagement and operating leverage reinforcing a bullish growth outlook.
The news is likely positive for HNGE as strong earnings, improved guidance, and product expansion support investor confidence and upside momentum
Similar Companies in Healthcare
Other companies in the same sector with AI ratings